172 related articles for article (PubMed ID: 18572345)
1. Should acute treatment with inhaled beta agonists be withheld from patients with dyspnea who may have heart failure?
Maak CA; Tabas JA; McClintock DE
J Emerg Med; 2011 Feb; 40(2):135-45. PubMed ID: 18572345
[TBL] [Abstract][Full Text] [Related]
2. Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease.
Singer AJ; Emerman C; Char DM; Heywood JT; Kirk JD; Hollander JE; Summers R; Lee CC; Wynne J; Kellerman L; Peacock WF
Ann Emerg Med; 2008 Jan; 51(1):25-34. PubMed ID: 17949853
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
4. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
5. Association between chronic heart failure and inhaled beta-2-adrenoceptor agonists.
Au DH; Udris EM; Curtis JR; McDonell MB; Fihn SD;
Am Heart J; 2004 Nov; 148(5):915-20. PubMed ID: 15523327
[TBL] [Abstract][Full Text] [Related]
6. Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study.
Gonnelli S; Caffarelli C; Maggi S; Guglielmi G; Siviero P; Rossi S; Crepaldi G; Nuti R;
Calcif Tissue Int; 2010 Aug; 87(2):137-43. PubMed ID: 20567964
[TBL] [Abstract][Full Text] [Related]
7. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists.
Hawkins NM; Petrie MC; Macdonald MR; Jhund PS; Fabbri LM; Wikstrand J; McMurray JJ
J Am Coll Cardiol; 2011 May; 57(21):2127-38. PubMed ID: 21596228
[TBL] [Abstract][Full Text] [Related]
8. Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD.
Ichinose M; Seyama K; Nishimura M; Fukuchi Y; Nagai A; Mishima M; Kubo K;
Respir Med; 2010 Feb; 104(2):267-74. PubMed ID: 19875277
[TBL] [Abstract][Full Text] [Related]
9. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
Gordon E; Lazarus SC
J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
[TBL] [Abstract][Full Text] [Related]
10. Are beta2-agonists responsible for increased mortality in heart failure?
Bermingham M; O'Callaghan E; Dawkins I; Miwa S; Samsudin S; McDonald K; Ledwidge M
Eur J Heart Fail; 2011 Aug; 13(8):885-91. PubMed ID: 21791542
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic determinants of dyspnea improvement in acute decompensated heart failure.
Solomonica A; Burger AJ; Aronson D
Circ Heart Fail; 2013 Jan; 6(1):53-60. PubMed ID: 23152491
[TBL] [Abstract][Full Text] [Related]
12. Cardiac asthma: new insights into an old disease.
Tanabe T; Rozycki HJ; Kanoh S; Rubin BK
Expert Rev Respir Med; 2012 Dec; 6(6):705-14. PubMed ID: 23234454
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
Matera MG; Martuscelli E; Cazzola M
Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
[TBL] [Abstract][Full Text] [Related]
14. Impact of chronic systolic heart failure on lung structure-function relationships in large airways.
Chase SC; Wheatley CM; Olson LJ; Beck KC; Wentz RJ; Snyder EM; Taylor BJ; Johnson BD
Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27418546
[TBL] [Abstract][Full Text] [Related]
15. An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure.
Thorneloe KS; Cheung M; Bao W; Alsaid H; Lenhard S; Jian MY; Costell M; Maniscalco-Hauk K; Krawiec JA; Olzinski A; Gordon E; Lozinskaya I; Elefante L; Qin P; Matasic DS; James C; Tunstead J; Donovan B; Kallal L; Waszkiewicz A; Vaidya K; Davenport EA; Larkin J; Burgert M; Casillas LN; Marquis RW; Ye G; Eidam HS; Goodman KB; Toomey JR; Roethke TJ; Jucker BM; Schnackenberg CG; Townsley MI; Lepore JJ; Willette RN
Sci Transl Med; 2012 Nov; 4(159):159ra148. PubMed ID: 23136043
[TBL] [Abstract][Full Text] [Related]
16. The lung water cascade in heart failure.
Picano E; Scali MC
Echocardiography; 2017 Oct; 34(10):1503-1507. PubMed ID: 28849591
[TBL] [Abstract][Full Text] [Related]
17. Impaired cardiac and peripheral hemodynamic responses to inhaled β₂-agonist in cystic fibrosis.
Van Iterson EH; Karpen SR; Baker SE; Wheatley CM; Morgan WJ; Snyder EM
Respir Res; 2015 Sep; 16(1):103. PubMed ID: 26341519
[TBL] [Abstract][Full Text] [Related]
18. [Acute decompensated heart failure].
Harada K
Nihon Rinsho; 2013 Jun; 71(6):1035-41. PubMed ID: 23855210
[TBL] [Abstract][Full Text] [Related]
19. Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction.
Au DH; Udris EM; Fan VS; Curtis JR; McDonell MB; Fihn SD
Chest; 2003 Jun; 123(6):1964-9. PubMed ID: 12796175
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of the congested lung.
Szidon JP
Cardiol Clin; 1989 Feb; 7(1):39-48. PubMed ID: 2650873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
